Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay

Journal of Infectious Diseases

Volumn 219, Issue 3, 2019, Pages 437-447

  Plucinski, Mateusz M ^a,b   Herman, Camelia ^a,c   Jones, Sophie ^a,e   Dimbu, Rafael ^d   Fortes, Filomeno ^d   Ljolje, Dragan ^a,e   Lucchi, Naomi ^a   Murphy, Sean C ^f,g   Smith, Nahum T ^f   Cruz, Kurtis R ^f   Seilie, Annette M ^f   Halsey, Eric S ^a,b   Udhayakumar, Venkatachalam ^a   Aidoo, Michael ^a   Rogier, Eric ^a,b  

^a Division of Parasitic Diseases and Malaria   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CDC FOUNDATION   (United States)

^d Ministry of Health   (Angola)

^e ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^f Department of Laboratory Medicine ^*  (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

antigen detection; malaria; multiplex immunoassay; non falciparum malaria; Pfhrp2 deletion

Indexed keywords

FRUCTOSE BISPHOSPHATE ALDOLASE; LACTATE DEHYDROGENASE; PLASMODIUM FALCIPARUM HISTIDINE RICH PROTEIN 2; PROTEIN PLASMODIUM ALDOLASE; PROTEIN PLASMODIUM LACTATE DEHYDROGENASE; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG; HRP-2 ANTIGEN, PLASMODIUM FALCIPARUM; HRP3 PROTEIN, PLASMODIUM FALCIPARUM; PARASITE ANTIGEN; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; ANGOLAN; ANTIGEN DETECTION; ANTIGEN PURIFICATION; ARTICLE; BLOOD SAMPLING; CHILD; ENDEMIC DISEASE; HUMAN; IMMUNOASSAY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALARIA; OUTPATIENT; PLASMODIUM FALCIPARUM; PLASMODIUM OVALE MALARIA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; YOUNG ADULT; ANGOLA; BLOOD; GENE DELETION; GENETICS; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; INFANT; MALARIA FALCIPARUM; MIDDLE AGED; PARASITOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANGOLA; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENE DELETION; HUMANS; IMMUNOLOGIC TESTS; INFANT; L-LACTATE DEHYDROGENASE; MALARIA, FALCIPARUM; MIDDLE AGED; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 85059797217     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiy525     Document Type: Article

References (38)

1. Tritten L, Matile H, Brun R, Wittlin S. A new double-antibody sandwich ELISA targeting Plasmodium falciparum aldolase to evaluate anti-malarial drug sensitivity. Malar J 2009; 8:226.
2. Noedl H, Wernsdorfer WH, Miller RS, Wongsrichanalai C. Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob Agents Chemother 2002; 46:1658-64.
3. Hendriksen IC, White LJ, Veenemans J, et al. Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration. J Infect Dis 2013; 207:351-61.
4. Aydin-Schmidt B, Mubi M, Morris U, et al. Usefulness of Plasmodium falciparum-specific rapid diagnostic tests for assessment of parasite clearance and detection of recurrent infections after artemisinin-based combination therapy. Malar J 2013; 12:349.
5. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev 2002; 15:66-78.
6. Mouatcho JC, Goldring JP. Malaria rapid diagnostic tests: challenges and prospects. J Med Microbiol 2013; 62:1491-505.
7. World Health Oganization. World malaria report 2015. www.who.int/malaria. Accessed 10 September 2018.
8. Noedl H, Yingyuen K, Laoboonchai A, Fukuda M, Sirichaisinthop J, Miller RS. Sensitivity and specificity of an antigen detection ELISA for malaria diagnosis. Am J Trop Med Hyg 2006; 75:1205-8.
9. Rogier E, Plucinski M, Lucchi N, et al. Bead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic tests. PLoS One 2017; 12:e0172139.
10. Plucinski M, Dimbu R, Candrinho B, et al. Malaria surveys using rapid diagnostic tests and validation of results using post hoc quantification of Plasmodium falciparum histidine-rich protein 2. Malar J 2017; 16:451.
11. Plucinski MM, Rogier E, Dimbu PR, Fortes F, Halsey ES, Aidoo M. Estimating the added utility of highly sensitive histidine-rich protein 2 detection in outpatient clinics in Sub-Saharan Africa. Am J Trop Med Hyg 2017; 97:1159-62.
12. Parra ME, Evans CB, Taylor DW. Identification of Plasmodium falciparum histidine-rich protein 2 in the plasma of humans with malaria. J Clin Microbiol 1991; 29:1629-34.
13. Iqbal J, Siddique A, Jameel M, Hira PR. Persistent histidine-rich protein 2, parasite lactate dehydrogenase, and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection. J Clin Microbiol 2004; 42:4237-41.
14. Plucinski MM, Dimbu PR, Fortes F, et al. Posttreatment HRP2 clearance in patients with uncomplicated Plasmodium falciparum malaria. J Infect Dis 2018; 217:685-92.
15. Nyunt MH, Kyaw MP, Win KK, Myint KM, Nyunt KM. Field evaluation of HRP2 and pan pLDH-based immunochromatographic assay in therapeutic monitoring of uncomplicated falciparum malaria in Myanmar. Malar J 2013; 12:123.
16. World Health Organization. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein, 2016. www.who.int/malaria. Accessed 10 September 2018.
17. Gamboa D, Ho MF, Bendezu J, et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One 2010; 5:e8091.
18. Bharti PK, Chandel HS, Ahmad A, Krishna S, Udhayakumar V, Singh N. Prevalence of pfhrp2 and/or pfhrp3 gene deletion in Plasmodium falciparum population in eight highly endemic states in India. PLoS One 2016; 11:e0157949.
19. Amoah LE, Abankwa J, Oppong A. Plasmodium falciparum histidine rich protein-2 diversity and the implications for PfHRP 2: based malaria rapid diagnostic tests in Ghana. Malar J 2016; 15:101.
20. Koita OA, Doumbo OK, Ouattara A, et al. False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am J Trop Med Hyg 2012; 86:194-8.
21. Wurtz N, Fall B, Bui K, et al. Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests. Malar J 2013; 12:34.
22. Parr JB, Verity R, Doctor SM, et al. Pfhrp2-deleted Plasmodium falciparum parasites in the Democratic Republic of the Congo: a national cross-sectional survey. J Infect Dis 2017; 216:36-44.
23. Cheng Q, Gatton ML, Barnwell J, et al. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar J 2014; 13:283.
24. Plucinski MM, Ferreira M, Ferreira CMF, et al. Evaluating malaria case management at public health facilities in two provinces in Angola. Malar J 2017; 16:186.
25. Jani IV, Janossy G, Brown DW, Mandy F. Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings. Lancet Infect Dis 2002; 2:243-50.
26. Hawkes M, Conroy AL, Opoka RO, et al. Use of a threeband HRP2/pLDH combination rapid diagnostic test increases diagnostic specificity for falciparum malaria in Ugandan children. Malar J 2014; 13:43.
27. President's Malaria Initiative. Angola National Malaria Strategic Plan 2016-2020. Luanda, Angola: Ministry of Health, 2015.
28. Doctor SM, Liu Y, Anderson OG, et al. Low prevalence of Plasmodium malariae and Plasmodium ovale mono-infections among children in the Democratic Republic of the Congo: a population-based, cross-sectional study. Malar J 2016; 15:350.
29. Gabrielli S, Bellina L, Milardi GL, et al. Malaria in children of Tshimbulu (Western Kasai, Democratic Republic of the Congo): epidemiological data and accuracy of diagnostic assays applied in a limited resource setting. Malar J 2016; 15:81.
30. Cao Y, Wang W, Liu Y, et al. The increasing importance of Plasmodium ovale and Plasmodium malariae in a malaria elimination setting: an observational study of imported cases in Jiangsu Province, China, 2011-2014. Malar J 2016; 15:459.
31. Ruas R, Pinto A, Nuak J, Sarmento A, Abreu C. Nonfalciparum malaria imported mainly from Africa: a review from a Portuguese hospital. Malar J 2017; 16:298.
32. Lupi O, Ridolfi F, da Silva S, et al. Dengue infection as a potential trigger of an imported Plasmodium ovale malaria relapse or a long incubation period in a non-endemic malaria region. Int J Infect Dis 2016; 44:20-4.
33. Rojo-Marcos G, Rubio-Munoz JM, Ramirez-Olivencia G, et al. Comparison of imported Plasmodium ovale curtisi and P. ovale wallikeri infections among patients in Spain, 2005-2011. Emerg Infect Dis 2014; 20:409-16.
34. Plucinski MM, Candrinho B, Chambe G, et al. Multiplex serology for impact evaluation of bed net distribution on burden of lymphatic filariasis and four species of human malaria in northern Mozambique. PLoS Negl Trop Dis 2018; 12:e0006278.
35. Bashir IM, Otsyula N, Awinda G, Spring M, Schneider P, Waitumbi JN. Comparison of PfHRP-2/pLDH ELISA, qPCR and microscopy for the detection of plasmodium events and prediction of sick visits during a malaria vaccine study. PLoS One 2013; 8:e56828.
36. Atchade PS, Doderer-Lang C, Chabi N, et al. Is a Plasmodium lactate dehydrogenase (pLDH) enzymelinked immunosorbent (ELISA)-based assay a valid tool for detecting risky malaria blood donations in Africa? Malar J 2013; 12:279.
37. Bharti PK, Chandel HS, Ahmad A, Krishna S, Udhayakumar V, Singh N. Prevalence of pfhrp2 and/or pfhrp3 gene deletion in Plasmodium falciparum population in eight highly endemic states in India. PLoS One 2016; 11:e0157949.
38. Biswas S, Tomar D, Rao DN. Investigation of the kinetics of histidine-rich protein 2 and of the antibody responses to this antigen, in a group of malaria patients from India. Ann Trop Med Parasitol 2005; 99:553-62.